ArticleExperimental and therapeutic medicine2011

Octreotide enhances the sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin chemotherapy in vitro.

Yang Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.